Nonspecific Low Back Pain

Nonspecific low back pain (NSLBP) is defined as low back pain not attributable to a recognisable specific pathology (such as infection, tumour, osteoporosis, fracture, structural deformity, inflammatory disorder, radicular syndrome, or cauda equina syndrome). It accounts for approximately 90% of all low back pain presentations in primary care and is the leading cause of years lived with disability globally and in Australia.

The 2018 Lancet series on low back pain identified three major evidence-practice gaps in the management of NSLBP: overuse of imaging and passive treatments, underuse of active exercise-based therapies, and inappropriate prescribing of opioids and spinal surgery. Australia's national guidelines and the ACSQHC Choosing Wisely program specifically target these gaps.

Understanding prognosis is essential for counselling patients and preventing iatrogenic harm through over-medicalisation. The natural history of acute NSLBP is generally favourable, but recurrence and chronification are common.

Natural History

• ~30–60% of patients recover within 6 weeks with minimal intervention
• ~80–90% improve significantly within 12 weeks
• However, complete resolution is less common than previously thought — many patients have recurrent episodes or low-level persistent pain
• ~10–15% of acute NSLBP transitions to chronic NSLBP (>12 weeks) — this subgroup accounts for the majority of costs and disability

Prognostic Factors — Predictors of Poor Outcome

Recurrence

Recurrence of NSLBP is extremely common — approximately 33–75% of patients have a recurrence within 12 months of an acute episode. Each recurrence carries a risk of prolonged disability. Active prevention strategies (exercise, ergonomics) are important after recovery.

Assessment of NSLBP serves two key purposes: (1) ruling out serious specific pathology (red flags), and (2) identifying psychosocial yellow flags that predict poor prognosis and guide management stratification.

Diagnostic Triage

• Specific spinal pathology (1–5%): Malignancy, infection, fracture, inflammatory arthropathy, cauda equina — red flags present → urgent investigation
• Nerve root pain / radiculopathy (5–10%): Dermatomal pain below knee, positive SLR, neurological signs → targeted management (see Back Pain Overview guideline)
• Nonspecific low back pain (~90%): No red flags, no neurological signs, no specific pathology identified → biopsychosocial management

STarT Back Screening Tool

The STarT Back Screening Tool (9-item questionnaire) is recommended at the first consultation for NSLBP. It stratifies patients into low, medium, and high risk groups based on psychosocial factors, guiding matched treatment intensity.

Clinical Examination Essentials

• Confirm absence of red flags (neurological exam, percussion over spine, temperature)
• Assess lumbar range of motion and pain behaviour
• Screen for hip pathology (mimics LBP — FABER/FADIR tests)
• No routine imaging required for NSLBP without red flags
• Assess functional impact: ability to work, activities of daily living

Routine imaging for NSLBP is NOT recommended and causes harm. Imaging findings (disc degeneration, disc bulges, facet arthropathy, Schmorl's nodes) are present in up to 80% of asymptomatic adults over 50 years. Showing these findings to patients increases fear-avoidance, medicalisation, and likelihood of surgery without improving outcomes.

• Inv-Essential
  No Imaging (Acute NSLBP, No Red Flags)

  Australian guidelines recommend AGAINST imaging for NSLBP without red flags in the first 4–6 weeks. MBS item numbers for lumbar X-ray/MRI require documentation of clinical indication beyond non-specific pain. Audit of imaging practices is a key NSQHS Standard 3 quality indicator.
• Inv-Essential
  Plain X-Ray — Only if Red Flags Present

  Indicated for: suspected fracture (osteoporosis, major trauma), suspected ankylosing spondylitis (AP pelvis for sacroiliitis), or structural deformity. Not useful for diagnosing NSLBP.
• Inv-Recommended
  MRI — Only if Red Flags or Persistent Radiculopathy

  Reserve for: suspected serious pathology, cauda equina, or radiculopathy not resolving after 4–6 weeks of appropriate conservative management. Not recommended for NSLBP without neurological features.
• Inv-Essential
  Blood Tests (if red flags present)

  FBC, ESR, CRP, LDH, protein electrophoresis — if malignancy suspected. ESR/CRP if infection or inflammatory arthritis suspected. No routine bloods needed for NSLBP.

Matched-care stratification using validated tools ensures patients receive the right intensity of treatment. The STarT Back Tool is the most widely adopted instrument in Australian primary care for NSLBP stratification.

STarT Back Tool — Scoring

The STarT Back Tool contains 9 questions. Items 5–9 form the 'subscale' (psychological items). Total score and subscale score determine risk stratum:

Örebro Musculoskeletal Pain Screening Questionnaire (OMPSQ)

The OMPSQ is a validated 25-item questionnaire that predicts work absenteeism and disability. Scores >105/210 indicate high risk of chronic disability and work loss — triggers early referral to occupational physiotherapy and workplace intervention. Particularly useful in occupational/workers' compensation contexts.

Comorbidity Assessment

• Screen for depression (PHQ-9) and anxiety (GAD-7) — significantly comorbid with chronic NSLBP and require concurrent management
• Sleep disturbance assessment — poor sleep perpetuates pain and impairs recovery
• Substance use assessment — alcohol and opioid misuse risk factors (AUDIT-C, ORT)
• Functional capacity: ability to work, self-care, social participation

Acute NSLBP (<6 weeks) management centres on reassurance, encouraging activity, and targeted analgesia. The evidence strongly supports active over passive approaches. Most patients recover within 6 weeks with minimal intervention.

First-Line: Reassurance and Education

• Explain the benign, self-limiting nature of acute NSLBP — 90% recover significantly within 6 weeks
• Avoid nocebo messaging: Do NOT say "your disc is worn out", "you have degeneration", or "avoid all bending" — these increase fear-avoidance and disability
• Use positive, empowering language: "your back is strong", "movement helps healing", "staying active is the best medicine"
• Provide written self-management information (e.g. BackBook, my back guide)
• Explain that imaging is not needed and does not change management — provide rationale

Stay Active — Core Advice

Analgesia for Acute NSLBP

Chronic NSLBP (>12 weeks) is a complex biopsychosocial condition requiring a multimodal, active approach. Passive treatments, opioids, and repeated imaging are ineffective and harmful in this group. The goal shifts from pain elimination to functional restoration and quality of life improvement.

Evidence Hierarchy for Chronic NSLBP

• Strong evidence (recommend): Exercise therapy, cognitive behavioural therapy, multidisciplinary pain rehabilitation programs, duloxetine (SNRI)
• Moderate evidence (consider): Manual therapy (spinal manipulation), acupuncture (short-term), low-level laser therapy, NSAIDs (short-term)
• Weak/no evidence (avoid): Opioids (long-term), gabapentinoids, systemic corticosteroids, bed rest, passive treatments as sole modality, spinal fusion (without structural indication)

Pharmacotherapy for Chronic NSLBP

Nonpharmacological therapies are the cornerstone of NSLBP management at all stages. For acute NSLBP, simple advice and activity are sufficient. For chronic NSLBP, structured nonpharmacological programs produce the largest and most durable benefits.

Exercise Therapy

• Most effective intervention for chronic NSLBP: Supervised exercise reduces pain (SMD ~0.5) and disability (SMD ~0.6) versus usual care
• Type of exercise: Evidence does not strongly favour any single modality — general aerobic exercise, core stabilisation, yoga, tai chi, Pilates, aquatic exercise, and walking all have comparable evidence
• Adherence is the key determinant: The best exercise is the one the patient will actually do
• Dosing: Minimum 8–12 weeks of supervised exercise; 2–3 sessions/week; progress intensity over time
• Referral: GP-referred exercise physiology (Medicare EPC plan, 5 sessions) or physiotherapy

Staying Active and Return to Work

• Return to work (even with modified duties) is therapeutic — improves outcomes compared to prolonged sick leave
• Advise patients that performing normal activities will not cause harm
• Graded activity programs: gradually increase activity level despite pain (not wait for pain to go away before resuming activity)
• For workers with physically demanding jobs: workplace assessment, ergonomic modifications, graduated return-to-work plan
• Provide GP management plan for allied health referral (Medicare EPC — up to 5 allied health visits per year)

Prevention of Work-Related Disability

• Identify yellow flags early (high STarT Back or OMPSQ score) — refer promptly to psychologically-informed physiotherapy
• Avoid medicalising NSLBP in the workplace — avoid recommending extended sick leave beyond 2–4 weeks for non-specific pain
• Coordinate with employers, occupational physiotherapists, and occupational physicians for graduated return-to-work plans
• Workers' compensation systems: Early intervention prevents claim escalation — involve insurer case managers early in complex cases

Passive Physical Treatments

Passive physical treatments (massage, ultrasound, TENS, heat, acupuncture, spinal manipulation) have modest, short-term benefits for NSLBP. They should only be used as adjuncts to active therapies — not as standalone long-term treatment.

• Spinal manipulation/mobilisation (physiotherapy/chiropractic): Modest short-term benefit for acute and chronic NSLBP; not superior to other active treatments
• Massage: Short-term pain relief; limited long-term benefit without exercise component
• Acupuncture: Modest short-term pain reduction (NNT ~8); not superior to sham acupuncture in high-quality trials
• TENS, ultrasound: No clinically significant benefit over sham in high-quality trials; not recommended as primary treatment
• Heat therapy: Simple, inexpensive; modest acute pain relief; acceptable as short-term adjunct

Psychological interventions target the psychosocial drivers of chronic NSLBP. They are among the most effective treatments for established chronic NSLBP with significant fear-avoidance, catastrophising, or comorbid mental health issues.

Cognitive Behavioural Therapy (CBT)

• Addresses maladaptive pain beliefs (fear-avoidance, catastrophising), pain behaviours, and emotional responses
• Delivered by psychologist (Medicare Better Access scheme — up to 10 sessions with GP mental health plan) or CBT-trained physiotherapist
• Group-based CBT programs (pain management programs) are as effective as individual CBT and more cost-effective
• NNT for CBT: ~3–5 for meaningful reduction in disability in chronic LBP

Acceptance and Commitment Therapy (ACT)

• Third-wave CBT approach — focuses on psychological flexibility and values-based living despite pain
• Particularly effective for patients with high pain catastrophising and who have not responded to traditional CBT
• Growing evidence base for chronic NSLBP — comparable to CBT for disability outcomes

Psychologically-Informed Physiotherapy (PIF)

• Physiotherapy incorporating CBT principles — addresses fear-avoidance within physical treatment sessions
• Specifically recommended for STarT Back high-risk group
• Physiotherapists with training in PIF deliver graded activity, fear exposure, and cognitive reframing alongside physical treatment
• More effective than standard physiotherapy for high-risk patients (NNT ~4 for disability at 12 months)

Multidisciplinary Pain Rehabilitation Programs

• The most effective intervention for severe chronic NSLBP with high disability
• Combines physiotherapy, psychology, occupational therapy, and medical input in a coordinated program
• Delivered in specialist pain clinics — typically 4–8 week intensive programs (inpatient or day program)
• Referral to specialist pain clinic appropriate when: >6 months chronic pain, significant disability, failed multiple treatments, high psychosocial burden
• Medicare funding: pain clinic referral via specialist (requires specialist GP management plan)

🤰 Pregnancy

NSLBP affects up to 70% of pregnant women, particularly as a pelvic girdle pain variant. Management is predominantly non-pharmacological.

• Physiotherapy, hydrotherapy, pelvic floor exercises — safe and effective throughout pregnancy
• Sacropelvic belt may reduce pelvic girdle pain
• Paracetamol: first-line if analgesia required; NSAIDs contraindicated after 20 weeks
• Reassure that NSLBP in pregnancy rarely persists postpartum in most cases; postnatal physiotherapy if persists

👴 Elderly Patients

• Confirm NSLBP diagnosis carefully — osteoporotic vertebral fracture presents acutely and may masquerade as NSLBP; DXA assessment if fracture risk factors present
• Exercise therapy remains the most effective treatment — chair-based exercise, hydrotherapy, tai chi all appropriate
• NSAIDs with great caution — renal function, cardiovascular and GI risk; prefer topical diclofenac gel
• Avoid opioids — falls, cognitive impairment, constipation; not recommended
• Pain psychology referral beneficial for chronic NSLBP in older adults

💼 Occupational / Workers' Compensation

• Avoid prolonged work absence — return to modified duties as soon as possible
• Involve insurer case manager and occupational physiotherapist early
• Address psychosocial barriers to return-to-work explicitly
• Medico-legal reporting: document functional capacity, not just pain intensity; avoid catastrophising language in reports

🛡️ Patients with Comorbid Mental Health Conditions

• Depression and anxiety are both consequences and contributors to chronic NSLBP — treat concurrently
• Duloxetine: indicated for both depression and chronic musculoskeletal pain — preferred pharmacological option
• Prioritise psychological intervention (CBT, ACT) alongside physiotherapy
• Avoid opioids in patients with depression — associated with higher overdose risk and worsening depression

Stewardship for NSLBP focuses on avoiding the four major categories of low-value care identified in the 2018 Lancet series: (1) unnecessary imaging, (2) opioid prescribing, (3) passive treatments as sole intervention, and (4) surgery for nonspecific pain.

Opioid Tapering in Chronic NSLBP

• For patients already on opioids for NSLBP, tapering is indicated — long-term opioids maintain dependence and worsen function
• Tapering approach: reduce by 5–10% of original dose every 2–4 weeks; monitor withdrawal symptoms
• Support with: CBT, buprenorphine-naloxone (Suboxone) for opioid-dependent patients, specialist addiction medicine referral if needed
• Opioid tapering is associated with reduced pain (via reversal of opioid-induced hyperalgesia) and improved function in many patients

Gabapentinoid Stewardship

• Pregabalin and gabapentin have NO evidence of benefit for NSLBP and cause significant harms: dizziness, falls, cognitive impairment, dependence
• Do not initiate for NSLBP; if already prescribed, taper and cease
• Evidence base: multiple RCTs show pregabalin is no better than placebo for non-radicular LBP (Mathieson 2017, Lancet)

Structured follow-up prevents chronification, monitors treatment response, and facilitates timely escalation when needed. Prevention of recurrence through active lifestyle modification is an integral part of NSLBP management.

Prevention of Recurrence

• Exercise: Regular exercise (minimum 150 min/week aerobic + 2x strength training) is the most evidence-based recurrence prevention strategy
• Maintain healthy weight: Reduce lumbar load and systemic inflammation
• Workplace ergonomics: Ergonomic workstation assessment; avoid prolonged static postures; take regular movement breaks (every 30–45 minutes)
• Avoid prolonged bed rest or sick leave: Both predict recurrence and chronification
• Address modifiable psychosocial factors: Treat depression and anxiety; improve job satisfaction where possible
• Smoking cessation: Smoking impairs disc nutrition and delays recovery

• 01
  Hartvigsen J, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356–2367.
• 02
  Foster NE, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368–2383.
• 03
  Buchbinder R, et al. Low back pain: a call for action. Lancet. 2018;391(10137):2384–2388.
• 04
  Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747.
• 05
  Australian Commission on Safety and Quality in Health Care (ACSQHC). Evidence-Based Care in Musculoskeletal Conditions: Low Back Pain. Sydney: ACSQHC; 2021.
• 06
  Hill JC, et al. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378(9802):1560–1571.
• 07
  Waddell G, et al. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain. 1993;52(2):157–168.
• 08
  Mathieson S, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376(12):1111–1120.
• 09
  Saragiotto BT, et al. Motor control exercise for nonspecific low back pain: a Cochrane review. Spine. 2016;41(16):1284–1295.
• 10
  Kamper SJ, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444.
• 11
  Williams ACC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11:CD007407.
• 12
  Royal Australian College of General Practitioners (RACGP). Prescribing drugs of dependence in general practice — Part C2: The role of opioids in pain management. Melbourne: RACGP; 2020.
• 13
  Australian Rheumatology Association. Clinical guidelines for nonspecific musculoskeletal pain management. Sydney: ARA; 2022.